首页 > 最新文献

Gates Open Research最新文献

英文 中文
Using responsive feedback from routine monitoring data to guide course corrections for a family planning intervention in Nigeria 利用常规监测数据的响应性反馈指导尼日利亚计划生育干预的课程纠正
Pub Date : 2023-05-19 DOI: 10.12688/gatesopenres.14591.1
D. Meekers, O. Olutola, L. Abu Turk
Background: This paper aims to promote the use of interrupted time series analyses of routine data as a responsive feedback tool to improve public health programs on an ongoing basis. This methodology is demonstrated by measuring the effect of a radio campaign to promote a family planning call center in Nigeria on the demand for family planning information and explains how the results were used to adapt the program.   Methods: We used a single group interrupted time series design (ITS) as a responsive feedback mechanism to determine whether the radio campaign influenced use of the Honey&Banana call center. ITS is ideal when a control group is not available and assumes that an interruption of the trend in the outcome measure occurs after the intervention starts. ITS uses the pre-intervention trend to predict what would have happened if the intervention were absent.   Results: After conducting ITS analyses, the results show that the number of calls requesting family planning information increased throughout the campaign period, with a gain of about 500 additional calls per month, and then decreased after the campaign ended. However, the number of calls gained from the campaign was substantially lower than anticipated.   Conclusions: While end-of-project impact evaluations are necessary, there should be regular feedback system to provide program implementers with information about the status of the project, such as failures, successes, and areas of improvements. This would allow implementers to make necessary adjustments as needed throughout the intervention period. The finding that the radio campaign was not living up to expectations helped program implementers to end the campaign prematurely and re-allocate resources to a more promising activity. Our research shows that basic ITS analysis of routine data can be a useful tool for receiving regular feedback to guide programming improvements.
背景:本文旨在推广使用常规数据的中断时间序列分析作为一种响应反馈工具,以持续改进公共卫生计划。这一方法通过衡量在尼日利亚推广计划生育呼叫中心的广播活动对计划生育信息需求的影响来证明,并解释了如何利用结果来调整该计划。方法:我们使用单组中断时间序列设计(ITS)作为响应反馈机制,以确定无线电活动是否影响Honey&Banana呼叫中心的使用。当对照组不可用时,ITS是理想的,并且假设干预开始后结果测量的趋势中断。ITS使用干预前的趋势来预测如果没有干预会发生什么。结果:在进行ITS分析后,结果显示,在整个活动期间,要求提供计划生育信息的电话数量增加,每月增加约500个电话,然后在活动结束后减少。然而,从这场运动中获得的电话数量大大低于预期。结论:虽然项目结束影响评估是必要的,但应该有定期的反馈系统,为项目实施者提供有关项目状态的信息,如失败、成功和改进领域。这将使实施者能够在整个干预期间根据需要进行必要的调整。发现广播活动没有达到预期,有助于项目实施者过早结束活动,并将资源重新分配给更有希望的活动。我们的研究表明,对常规数据的基本ITS分析可以成为接收定期反馈以指导编程改进的有用工具。
{"title":"Using responsive feedback from routine monitoring data to guide course corrections for a family planning intervention in Nigeria","authors":"D. Meekers, O. Olutola, L. Abu Turk","doi":"10.12688/gatesopenres.14591.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14591.1","url":null,"abstract":"Background: This paper aims to promote the use of interrupted time series analyses of routine data as a responsive feedback tool to improve public health programs on an ongoing basis. This methodology is demonstrated by measuring the effect of a radio campaign to promote a family planning call center in Nigeria on the demand for family planning information and explains how the results were used to adapt the program.   Methods: We used a single group interrupted time series design (ITS) as a responsive feedback mechanism to determine whether the radio campaign influenced use of the Honey&Banana call center. ITS is ideal when a control group is not available and assumes that an interruption of the trend in the outcome measure occurs after the intervention starts. ITS uses the pre-intervention trend to predict what would have happened if the intervention were absent.   Results: After conducting ITS analyses, the results show that the number of calls requesting family planning information increased throughout the campaign period, with a gain of about 500 additional calls per month, and then decreased after the campaign ended. However, the number of calls gained from the campaign was substantially lower than anticipated.   Conclusions: While end-of-project impact evaluations are necessary, there should be regular feedback system to provide program implementers with information about the status of the project, such as failures, successes, and areas of improvements. This would allow implementers to make necessary adjustments as needed throughout the intervention period. The finding that the radio campaign was not living up to expectations helped program implementers to end the campaign prematurely and re-allocate resources to a more promising activity. Our research shows that basic ITS analysis of routine data can be a useful tool for receiving regular feedback to guide programming improvements.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45159445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study of the effectiveness of a detergent-based California mastitis test (CMT), using Ethiopian and Nigerian domestic detergents, for the detection of high somatic cell counts in milk and their reliability compared to the commercial UK CMT. 使用埃塞俄比亚和尼日利亚国产洗涤剂,研究基于洗涤剂的加利福尼亚乳腺炎检验(CMT)检测牛奶中高体细胞数的有效性,以及与英国商用 CMT 相比的可靠性。
Pub Date : 2023-05-17 eCollection Date: 2021-01-01 DOI: 10.12688/gatesopenres.13369.2
Jack D Rust, Michael J Christian, Ciara J Vance, Muhammed B Bolajoko, Johanna T Wong, Jeimmy Suarez-Martinez, Fiona K Allan, Andrew R Peters

Background:  The California mastitis test (CMT) is a simple cow-side indicator of the somatic cell count (SCC) in milk, providing a useful tool in identifying cases of subclinical mastitis in cattle. Mastitis, and in particular subclinical mastitis, is a major concern in Ethiopia and Nigeria, yet detection is challenging due to cost and access to commercial CMT reagents. Methods: Commercially available domestic detergents from Ethiopia and Nigeria were compared (n = 3 for each country) with the UK commercial CMT reagent in their ability to detect high SCC (>400,000 cells/ml milk).  Sensitivity and specificity of the CMT test were calculated for the different detergents and positive and negative predictive values were established. Results:  The average sensitivities of the tests ranged from 28-75% for the Ethiopian detergents and 68-80% for the Nigerian detergents, compared to 76% for the UK domestic detergent.  Test specificities were 84-98%, 93-97% and 96%, respectively. Conclusions:  Overall, the detergents demonstrated higher specificity than sensitivity.   Nigerian detergents performed better than the Ethiopian products, however, the study identified suitable domestic detergents from both Ethiopia and Nigeria, comparable to the UK commercial CMT reagent, and we recommend their use as alternative CMT reagents for livestock-keepers to aid in cost-effective diagnosis of mastitis.

背景: 加利福尼亚乳腺炎测试(CMT)是牛奶中体细胞数(SCC)的一个简单牛侧指标,为确定牛的亚临床乳腺炎病例提供了一个有用的工具。乳腺炎,尤其是亚临床乳腺炎,是埃塞俄比亚和尼日利亚的一个主要问题,但由于成本和商用 CMT 试剂的获取问题,检测工作面临挑战。方法:将埃塞俄比亚和尼日利亚的商用家用洗涤剂(每个国家 3 支)与英国商用 CMT 试剂在检测高 SCC(>400,000 个细胞/毫升牛奶)方面的能力进行比较。 计算了不同洗涤剂的 CMT 检测灵敏度和特异性,并确定了阳性和阴性预测值。结果 埃塞俄比亚洗涤剂的平均检测灵敏度为 28-75%,尼日利亚洗涤剂的平均检测灵敏度为 68-80%,而英国国产洗涤剂的平均检测灵敏度为 76%。 测试特异性分别为 84-98%、93-97% 和 96%。结论: 总体而言,洗涤剂的特异性高于敏感性。 尼日利亚的清洁剂比埃塞俄比亚的产品性能更好,但是,研究发现埃塞俄比亚和尼日利亚都有合适的国产清洁剂,可与英国的商用 CMT 试剂相媲美,我们建议将它们用作家畜饲养者的替代 CMT 试剂,以帮助进行经济有效的乳腺炎诊断。
{"title":"A study of the effectiveness of a detergent-based California mastitis test (CMT), using Ethiopian and Nigerian domestic detergents, for the detection of high somatic cell counts in milk and their reliability compared to the commercial UK CMT.","authors":"Jack D Rust, Michael J Christian, Ciara J Vance, Muhammed B Bolajoko, Johanna T Wong, Jeimmy Suarez-Martinez, Fiona K Allan, Andrew R Peters","doi":"10.12688/gatesopenres.13369.2","DOIUrl":"10.12688/gatesopenres.13369.2","url":null,"abstract":"<p><p><b>Background: </b> The California mastitis test (CMT) is a simple cow-side indicator of the somatic cell count (SCC) in milk, providing a useful tool in identifying cases of subclinical mastitis in cattle. Mastitis, and in particular subclinical mastitis, is a major concern in Ethiopia and Nigeria, yet detection is challenging due to cost and access to commercial CMT reagents. <b>Methods:</b> Commercially available domestic detergents from Ethiopia and Nigeria were compared (n = 3 for each country) with the UK commercial CMT reagent in their ability to detect high SCC (>400,000 cells/ml milk).  Sensitivity and specificity of the CMT test were calculated for the different detergents and positive and negative predictive values were established. <b>Results: </b> The average sensitivities of the tests ranged from 28-75% for the Ethiopian detergents and 68-80% for the Nigerian detergents, compared to 76% for the UK domestic detergent.  Test specificities were 84-98%, 93-97% and 96%, respectively. <b>Conclusions:</b> <b> </b>Overall, the detergents demonstrated higher specificity than sensitivity. <b> </b> Nigerian detergents performed better than the Ethiopian products, however, the study identified suitable domestic detergents from both Ethiopia and Nigeria, comparable to the UK commercial CMT reagent, and we recommend their use as alternative CMT reagents for livestock-keepers to aid in cost-effective diagnosis of mastitis.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"5 ","pages":"146"},"PeriodicalIF":0.0,"publicationDate":"2023-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10093957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Azithromycin in labour to reduce maternal and newborn sepsis and associated deaths: the need for a harmonized approach 分娩时使用阿奇霉素以减少孕产妇和新生儿败血症及相关死亡:需要统一的方法
Pub Date : 2023-05-16 DOI: 10.12688/gatesopenres.14214.1
E. Mcclure, A. Roca, K. Kotloff, W. Carlo, U. d’Alessandro, H. Tinto, Bully Camara, E. Chomba, S. Sow, A. Driscoll, J. Hemingway-Foday, A. Tita
Maternal and newborn infections are a major contributor to mortality and morbidity globally.  Lost-cost, effective and safe interventions are needed to address these.  Based on promising findings, azithromycin has been identified as potentially effective antibiotic to reduce maternal and newborn infections in low- and middle-income countries (LMICs).  However, robust randomized clinical trials in a range of settings are needed to confirm these findings as well as to understand the implications for antimicrobial resistance.  To better understand the impact of azithromycin on maternal and newborn health, at least three clinical trials are being conducted to evaluate azithromycin in LMICs.  We describe these trials, the importance of harmonizing study measures and the potential public health impact of azithromycin in LMICs.
孕产妇和新生儿感染是全球死亡率和发病率的主要原因。需要成本损失、有效和安全的干预措施来解决这些问题。基于有希望的发现,阿奇霉素已被确定为一种潜在的有效抗生素,可减少中低收入国家的孕产妇和新生儿感染。然而,需要在一系列环境中进行强有力的随机临床试验来证实这些发现,并了解其对抗菌药物耐药性的影响。为了更好地了解阿奇霉素对孕产妇和新生儿健康的影响,至少正在进行三项临床试验来评估阿奇霉素在LMIC中的作用。我们描述了这些试验、协调研究措施的重要性以及阿奇霉素在LMIC中对公共健康的潜在影响。
{"title":"Azithromycin in labour to reduce maternal and newborn sepsis and associated deaths: the need for a harmonized approach","authors":"E. Mcclure, A. Roca, K. Kotloff, W. Carlo, U. d’Alessandro, H. Tinto, Bully Camara, E. Chomba, S. Sow, A. Driscoll, J. Hemingway-Foday, A. Tita","doi":"10.12688/gatesopenres.14214.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14214.1","url":null,"abstract":"Maternal and newborn infections are a major contributor to mortality and morbidity globally.  Lost-cost, effective and safe interventions are needed to address these.  Based on promising findings, azithromycin has been identified as potentially effective antibiotic to reduce maternal and newborn infections in low- and middle-income countries (LMICs).  However, robust randomized clinical trials in a range of settings are needed to confirm these findings as well as to understand the implications for antimicrobial resistance.  To better understand the impact of azithromycin on maternal and newborn health, at least three clinical trials are being conducted to evaluate azithromycin in LMICs.  We describe these trials, the importance of harmonizing study measures and the potential public health impact of azithromycin in LMICs.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48798542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implication of the 2014 World Health Organization Integrated Management of Childhood Illness Pneumonia Guidelines with and without pulse oximetry use in Malawi: A retrospective cohort study 2014年世界卫生组织儿童疾病肺炎综合管理指南在马拉维使用和不使用脉搏血氧仪的含义:一项回顾性队列研究
Pub Date : 2023-05-15 DOI: 10.12688/gatesopenres.13963.1
S. Hooli, C. Makwenda, N. Lufesi, T. Colbourn, T. Mvalo, E. McCollum, C. King
Background: Under-5 pneumonia mortality remains high in low-income countries. In 2014 the World Health Organization (WHO) advised that children with chest indrawing pneumonia, but without danger signs or peripheral oxygen saturation (SpO2) < 90% be treated in the community, rather than hospitalized. In Malawi there is limited pulse oximetry availability. Methods: Secondary analysis of 13,413 under-5 pneumonia cases in Malawi. Pneumonia associated case fatality ratios (CFR) were calculated by disease severity under the assumptions of the 2005 and 2014 WHO Integrated Management of Childhood Illness (IMCI) guidelines, with and without pulse oximetry. We investigated if pulse oximetry readings were missing not at random (MNAR). Results: The CFR of patients classified as having non-severe pneumonia per the 2014 IMCI guidelines doubled under the assumption that pulse oximetry was not available (1.5% without pulse oximetry vs 0.7% with pulse oximetry, P<0.001). When 2014 IMCI guidelines were applied with pulse oximetry and a SpO2 < 90% as the threshold for referral and/or admission, the number of cases meeting hospitalization criteria decreased by 70.3%. Unrecorded pulse oximetry readings were MNAR with an adjusted odds for mortality of 4.9 (3.8, 6.3), similar to that of a SpO2 < 90%. Although fewer girls were hospitalized, female sex was an independent mortality risk factor. Conclusions: In Malawi, implementation of the 2014 WHO IMCI pneumonia guidelines, without pulse oximetry, will miss high risk cases. Alternatively, implementation of pulse oximetry may result in a large reduction in hospitalization rates without significantly increasing non-severe pneumonia associated CFR if the inability to obtain a pulse oximetry reading is considered a WHO danger sign.
背景:低收入国家的5岁以下肺炎死亡率仍然很高。2014年,世界卫生组织(世界卫生组织)建议,患有胸闷性肺炎但没有危险迹象或外周血氧饱和度(SpO2)<90%的儿童在社区接受治疗,而不是住院治疗。在马拉维,脉搏血氧计的可用性有限。方法:对马拉维13413例5岁以下儿童肺炎病例进行二次分析。根据2005年和2014年世界卫生组织儿童疾病综合管理(IMCI)指南的假设,在使用和不使用脉搏血氧计的情况下,根据疾病严重程度计算肺炎相关病死率(CFR)。我们调查了脉搏血氧计读数是否缺失,而不是随机的(MNAR)。结果:在假设脉搏血氧仪不可用的情况下,根据2014年IMCI指南被归类为非重症肺炎的患者的CFR翻了一番(没有脉搏血氧法的患者为1.5%,有脉搏血氧术的患者为0.7%,P<0.001)。当2014年IMMI指南以脉搏血氧计和SpO2<90%作为转诊和/或入院的阈值时,符合住院标准的病例数量减少了70.3%。未记录的脉搏血氧仪读数为MNAR,调整后的死亡率为4.9(3.8,6.3),类似于血氧饱和度<90%的情况。尽管住院的女孩较少,但女性是一个独立的死亡风险因素。结论:在马拉维,在没有脉搏血氧测定的情况下,实施2014年世界卫生组织IMCI肺炎指南将错过高风险病例。或者,如果无法获得脉搏血氧仪读数被认为是世界卫生组织的危险信号,那么实施脉搏血氧计可能会导致住院率大幅降低,而不会显著增加非严重肺炎相关病死率。
{"title":"Implication of the 2014 World Health Organization Integrated Management of Childhood Illness Pneumonia Guidelines with and without pulse oximetry use in Malawi: A retrospective cohort study","authors":"S. Hooli, C. Makwenda, N. Lufesi, T. Colbourn, T. Mvalo, E. McCollum, C. King","doi":"10.12688/gatesopenres.13963.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.13963.1","url":null,"abstract":"Background: Under-5 pneumonia mortality remains high in low-income countries. In 2014 the World Health Organization (WHO) advised that children with chest indrawing pneumonia, but without danger signs or peripheral oxygen saturation (SpO2) < 90% be treated in the community, rather than hospitalized. In Malawi there is limited pulse oximetry availability. Methods: Secondary analysis of 13,413 under-5 pneumonia cases in Malawi. Pneumonia associated case fatality ratios (CFR) were calculated by disease severity under the assumptions of the 2005 and 2014 WHO Integrated Management of Childhood Illness (IMCI) guidelines, with and without pulse oximetry. We investigated if pulse oximetry readings were missing not at random (MNAR). Results: The CFR of patients classified as having non-severe pneumonia per the 2014 IMCI guidelines doubled under the assumption that pulse oximetry was not available (1.5% without pulse oximetry vs 0.7% with pulse oximetry, P<0.001). When 2014 IMCI guidelines were applied with pulse oximetry and a SpO2 < 90% as the threshold for referral and/or admission, the number of cases meeting hospitalization criteria decreased by 70.3%. Unrecorded pulse oximetry readings were MNAR with an adjusted odds for mortality of 4.9 (3.8, 6.3), similar to that of a SpO2 < 90%. Although fewer girls were hospitalized, female sex was an independent mortality risk factor. Conclusions: In Malawi, implementation of the 2014 WHO IMCI pneumonia guidelines, without pulse oximetry, will miss high risk cases. Alternatively, implementation of pulse oximetry may result in a large reduction in hospitalization rates without significantly increasing non-severe pneumonia associated CFR if the inability to obtain a pulse oximetry reading is considered a WHO danger sign.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49196858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using models and maps to inform Target Product Profiles and Preferred Product Characteristics: the example of Wolbachia replacement 使用模型和地图来告知目标产品概况和首选产品特征:沃尔巴克氏菌替换的例子
Pub Date : 2023-05-12 DOI: 10.12688/gatesopenres.14300.1
Katie Tiley, J. Entwistle, Bruce Thomas, L. Yakob, O. Brady
Background The global prevalence of diseases transmitted by Aedes aegypti mosquitoes, such as dengue, Zika and Yellow Fever, is increasing, but development of promising new mosquito control technologies could reverse this trend. Target Product Profiles (TPPs) and Preferred Product Characteristics (PPCs) documents issued by the World Health Organization can guide the research and development pathways of new products and product combinations transitioning from proof of concept to operational use. Methods We used high resolution global maps of the case and economic burden of dengue to derive programmatic cost targets to support a TPP for Wolbachia replacement. A compartmental entomological model was used to explore how release size, spacing and timing affect replacement speed and acceptability. To support a PPC for a hybrid suppress-then-replace approach we tested whether Wolbachia replacement could be achieved faster, more acceptably or at a lower cost if preceded by a mosquito suppression programme. Results We show how models can reveal trade-offs, identify quantitative thresholds and prioritise areas and intervention strategies for further development. We estimate that for Wolbachia replacement to be deployable in enough areas to make major contributions to reducing global dengue burden by 25% (in line with 2030 WHO targets), cost must ultimately be reduced to between $7.63 and $0.24 (USD) per person protected or less. Suppression, particularly interventions that induce mosquito sterility, can reduce the number of Wolbachia mosquitoes necessary to achieve fixation by up to 80%. A hybrid approach can also achieve fixation faster and potentially improve acceptability, but may not justify their cost if they require major new investments in suppression technologies. Conclusions Here we demonstrate the value dedicated modelling can provide for interdisciplinary groups of experts when developing TPPs and PPCs. These models could be used by product developers to prioritise and shape development decisions for new Wolbachia replacement products.
登革热、寨卡病毒和黄热病等由埃及伊蚊传播的疾病在全球的流行率正在上升,但有希望的新型蚊虫控制技术的发展可能会扭转这一趋势。世界卫生组织发布的目标产品概况(TPPs)和首选产品特性(PPCs)文件可以指导新产品和产品组合从概念验证过渡到实际使用的研究和开发途径。方法使用登革热病例和经济负担的高分辨率全球地图,得出规划成本目标,以支持替代沃尔巴克氏体的跨太平洋伙伴关系。采用区隔昆虫学模型探讨了释放大小、间隔和时间对替换速度和可接受性的影响。为了支持PPC对混合抑制-替换方法的支持,我们测试了沃尔巴克氏体替换是否可以更快,更容易接受或以更低的成本实现,如果之前有一个蚊子抑制计划。我们展示了模型如何揭示权衡,确定定量阈值并优先考虑进一步发展的领域和干预策略。我们估计,若要在足够多的地区部署沃尔巴克氏体替代剂,从而为将全球登革热负担减少25%做出重大贡献(符合世卫组织2030年的目标),成本最终必须降低到每人受保护或更少7.63至0.24美元之间。抑制,特别是诱导蚊子不育的干预措施,可使实现固定所需的沃尔巴克氏体蚊子数量减少多达80%。混合方法也可以更快地实现固定,并可能提高可接受性,但如果需要在抑制技术上进行大量新投资,则可能无法证明其成本是合理的。在这里,我们证明了在开发TPPs和PPCs时,专用模型可以为跨学科专家小组提供价值。这些模型可以被产品开发人员用来确定新的沃尔巴克氏菌替代产品的优先级和形成开发决策。
{"title":"Using models and maps to inform Target Product Profiles and Preferred Product Characteristics: the example of Wolbachia replacement","authors":"Katie Tiley, J. Entwistle, Bruce Thomas, L. Yakob, O. Brady","doi":"10.12688/gatesopenres.14300.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14300.1","url":null,"abstract":"Background The global prevalence of diseases transmitted by Aedes aegypti mosquitoes, such as dengue, Zika and Yellow Fever, is increasing, but development of promising new mosquito control technologies could reverse this trend. Target Product Profiles (TPPs) and Preferred Product Characteristics (PPCs) documents issued by the World Health Organization can guide the research and development pathways of new products and product combinations transitioning from proof of concept to operational use. Methods We used high resolution global maps of the case and economic burden of dengue to derive programmatic cost targets to support a TPP for Wolbachia replacement. A compartmental entomological model was used to explore how release size, spacing and timing affect replacement speed and acceptability. To support a PPC for a hybrid suppress-then-replace approach we tested whether Wolbachia replacement could be achieved faster, more acceptably or at a lower cost if preceded by a mosquito suppression programme. Results We show how models can reveal trade-offs, identify quantitative thresholds and prioritise areas and intervention strategies for further development. We estimate that for Wolbachia replacement to be deployable in enough areas to make major contributions to reducing global dengue burden by 25% (in line with 2030 WHO targets), cost must ultimately be reduced to between $7.63 and $0.24 (USD) per person protected or less. Suppression, particularly interventions that induce mosquito sterility, can reduce the number of Wolbachia mosquitoes necessary to achieve fixation by up to 80%. A hybrid approach can also achieve fixation faster and potentially improve acceptability, but may not justify their cost if they require major new investments in suppression technologies. Conclusions Here we demonstrate the value dedicated modelling can provide for interdisciplinary groups of experts when developing TPPs and PPCs. These models could be used by product developers to prioritise and shape development decisions for new Wolbachia replacement products.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41542373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial 氨甲环酸预防贫血妇女产后出血:WOMAN-2试验的统计分析计划:一项国际、随机、安慰剂对照试验
Pub Date : 2023-05-12 DOI: 10.12688/gatesopenres.14529.1
Tim Collier, Haleema Shakur-Still, Ian Roberts, Eni Balogun, Oladapo Olayemi, Folasade Adenike Bello, Rizwana Chaudhri, Projestine Muganyizi
Background: Postpartum haemorrhage (PPH) is responsible for over 50,000 maternal deaths every year. Most of these deaths are in low- and middle-income countries. Tranexamic acid (TXA) reduces bleeding by inhibiting the enzymatic breakdown of fibrin blood clots. TXA decreases surgical bleeding and reduces deaths from bleeding after traumatic injury. When given within three hours of birth, TXA reduces deaths from bleeding in women with PPH. However, for many women, treatment of PPH is too late to prevent death. World-wide, over one-third of pregnant women are anaemic and many are severely anaemic. These women have an increased risk of PPH and are more likely to die if PPH occurs. There is an urgent need to identify ways to prevent severe postpartum bleeding in anaemic women. The WOMAN-2 trial will quantify the effects of TXA on postpartum bleeding in women with anaemia. Results: This statistical analysis plan (version 1.0; dated 22 February 2023) has been written based on information in the WOMAN-2 Trial protocol version 2.0, dated 30 June 2022. The primary outcome of the WOMAN-2 trial is the proportion of women with a clinical diagnosis of primary PPH. Secondary outcomes are maternal blood loss and its consequences (estimated blood loss, haemoglobin, haemodynamic instability, blood transfusion, signs of shock, use of interventions to control bleeding); maternal health and wellbeing (fatigue, headache, dizziness, palpitations, breathlessness, exercise tolerance, ability to care for her baby, health related quality of life, breastfeeding); and other health outcomes (deaths, vascular occlusive events, organ dysfunction, sepsis, side effects, time spent in higher level facility, length of hospital stay, and status of the baby). Conclusions: WOMAN-2 will provide reliable evidence about the effects of TXA in women with anaemia. Registration: WOMAN-2 was prospectively registered at the International Standard Randomised Controlled Trials registry (ISRCTN62396133) on 07/12/2017 and ClinicalTrials.gov on 23/03/2018 (NCT03475342).
背景:产后出血(PPH)每年造成5万多名产妇死亡。这些死亡大多发生在低收入和中等收入国家。氨甲环酸(TXA)通过抑制纤维蛋白血凝块的酶分解来减少出血。TXA减少手术出血,减少创伤后出血的死亡。如果在出生三小时内给予TXA,可减少PPH妇女因出血而死亡。然而,对许多妇女来说,治疗PPH为时已晚,无法预防死亡。在世界范围内,超过三分之一的孕妇患有贫血症,许多孕妇患有严重贫血症。这些妇女患PPH的风险增加,如果发生PPH,死亡的可能性更大。迫切需要确定预防贫血妇女产后严重出血的方法。WOMAN-2试验将量化TXA对贫血妇女产后出血的影响。结果:本统计分析方案(1.0版;日期为2023年2月22日)是根据日期为2022年6月30日的WOMAN-2试验方案2.0版中的信息编写的。WOMAN-2试验的主要终点是临床诊断为原发性PPH的女性比例。次要结局是产妇失血及其后果(估计失血量、血红蛋白、血流动力学不稳定、输血、休克迹象、采取干预措施控制出血);产妇保健和福利(疲劳、头痛、头晕、心悸、呼吸困难、运动耐受性、照顾婴儿的能力、与健康有关的生活质量、母乳喂养);以及其他健康结果(死亡、血管闭塞事件、器官功能障碍、败血症、副作用、在更高级别设施的时间、住院时间和婴儿状况)。结论:WOMAN-2将为TXA对贫血妇女的作用提供可靠的证据。注册:women -2于2017年12月07日在国际标准随机对照试验注册中心(ISRCTN62396133)和2018年3月23日在ClinicalTrials.gov (NCT03475342)前瞻性注册。
{"title":"Tranexamic acid for the prevention of postpartum bleeding in women with anaemia: Statistical analysis plan for the WOMAN-2 trial: an international, randomised, placebo-controlled trial","authors":"Tim Collier, Haleema Shakur-Still, Ian Roberts, Eni Balogun, Oladapo Olayemi, Folasade Adenike Bello, Rizwana Chaudhri, Projestine Muganyizi","doi":"10.12688/gatesopenres.14529.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14529.1","url":null,"abstract":"<ns4:p><ns4:bold>Background: </ns4:bold>Postpartum haemorrhage (PPH) is responsible for over 50,000 maternal deaths every year. Most of these deaths are in low- and middle-income countries. Tranexamic acid (TXA) reduces bleeding by inhibiting the enzymatic breakdown of fibrin blood clots. TXA decreases surgical bleeding and reduces deaths from bleeding after traumatic injury. When given within three hours of birth, TXA reduces deaths from bleeding in women with PPH. However, for many women, treatment of PPH is too late to prevent death. World-wide, over one-third of pregnant women are anaemic and many are severely anaemic. These women have an increased risk of PPH and are more likely to die if PPH occurs. There is an urgent need to identify ways to prevent severe postpartum bleeding in anaemic women. The WOMAN-2 trial will quantify the effects of TXA on postpartum bleeding in women with anaemia.</ns4:p><ns4:p> <ns4:bold>Results: </ns4:bold>This statistical analysis plan (version 1.0; dated 22 February 2023) has been written based on information in the WOMAN-2 Trial protocol version 2.0, dated 30 June 2022. The primary outcome of the WOMAN-2 trial is the proportion of women with a clinical diagnosis of primary PPH. Secondary outcomes are maternal blood loss and its consequences (estimated blood loss, haemoglobin, haemodynamic instability, blood transfusion, signs of shock, use of interventions to control bleeding); maternal health and wellbeing (fatigue, headache, dizziness, palpitations, breathlessness, exercise tolerance, ability to care for her baby, health related quality of life, breastfeeding); and other health outcomes (deaths, vascular occlusive events, organ dysfunction, sepsis, side effects, time spent in higher level facility, length of hospital stay, and status of the baby).</ns4:p><ns4:p> <ns4:bold>Conclusions: </ns4:bold>WOMAN-2 will provide reliable evidence about the effects of TXA in women with anaemia.</ns4:p><ns4:p> <ns4:bold>Registration: </ns4:bold>WOMAN-2 was prospectively registered at the International Standard Randomised Controlled Trials registry (<ns4:ext-link xmlns:ns5=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" ns5:href=\"https://www.isrctn.com/ISRCTN62396133\">ISRCTN62396133</ns4:ext-link>) on 07/12/2017 and ClinicalTrials.gov on 23/03/2018 (<ns4:ext-link xmlns:ns5=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" ns5:href=\"https://clinicaltrials.gov/ct2/show/NCT03475342\">NCT03475342</ns4:ext-link>).</ns4:p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135389185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The more, the better: influence of family planning discussions during the maternal, newborn and child health continuum of care on postpartum contraceptive uptake and method type among young women in Ethiopia. 越多越好:在孕产妇、新生儿和儿童健康连续护理期间,计划生育讨论对埃塞俄比亚年轻妇女产后避孕药具使用和方法类型的影响。
Pub Date : 2023-05-09 eCollection Date: 2023-01-01 DOI: 10.12688/gatesopenres.14626.1
Lisa M Calhoun, Jennifer Winston, Lenka Beňová, Ilene S Speizer, Thérèse Delvaux, Solomon Shiferaw, Assefa Seme, Celia Karp, Linnea Zimmerman, Thomas van den Akker

Background: This study examines the association between family planning (FP) discussions with health professionals during contact points on the maternal, newborn and child health continuum of care and timing of modern contraceptive uptake and method type in the one-year following childbirth in six regions of Ethiopia among adolescent girls and young women (AGYW). Methods: This paper uses panel data of women aged 15-24 who were interviewed during pregnancy and the postpartum period between 2019-2021 as part of the PMA Ethiopia survey (n=652).  Results: Despite the majority of pregnant and postpartum AGYW attending antenatal care (ANC), giving birth in a health facility, and attending vaccination visits, one-third or less of those who received the service reported discussion of FP at any of these visits. When considering the cumulative effect of discussions of FP at ANC, pre-discharge after childbirth, postnatal care and vaccination visits, we found that discussion of FP at a greater number of visits resulted in increased uptake of modern contraception by one-year postpartum. A greater number of FP discussions was associated with higher long-acting reversible contraceptive use relative to non-use and relative to short-acting method use. Conclusions: Despite high attendance, there are missed opportunities to discuss FP when AGYW access care.

背景:本研究考察了在埃塞俄比亚六个地区的少女和年轻妇女(AGYW)中,在接触点期间与卫生专业人员就孕产妇、新生儿和儿童健康连续护理进行的计划生育(FP)讨论与现代避孕药具使用时间和分娩后一年的方法类型之间的关系。方法:本文使用了2019-2021年期间在怀孕和产后接受采访的15-24岁女性的面板数据,作为PMA埃塞俄比亚调查的一部分(n=652)。结果:尽管大多数孕妇和产后AGYW参加了产前护理(ANC)、在卫生机构分娩和疫苗接种访问,但接受该服务的人中有三分之一或更少的人报告在任何这些访问中讨论过FP。在考虑ANC讨论FP、产后出院前、产后护理和疫苗接种访视的累积效应时,我们发现,在更多访视中讨论FP会导致产后一年对现代避孕的接受增加。与不使用和短效方法使用相比,更多的FP讨论与更高的长效可逆避孕药使用有关。结论:尽管出席率很高,但当AGYW获得护理时,仍错过了讨论FP的机会。
{"title":"The more, the better: influence of family planning discussions during the maternal, newborn and child health continuum of care on postpartum contraceptive uptake and method type among young women in Ethiopia.","authors":"Lisa M Calhoun, Jennifer Winston, Lenka Beňová, Ilene S Speizer, Thérèse Delvaux, Solomon Shiferaw, Assefa Seme, Celia Karp, Linnea Zimmerman, Thomas van den Akker","doi":"10.12688/gatesopenres.14626.1","DOIUrl":"10.12688/gatesopenres.14626.1","url":null,"abstract":"<p><p><b>Background:</b> This study examines the association between family planning (FP) discussions with health professionals during contact points on the maternal, newborn and child health continuum of care and timing of modern contraceptive uptake and method type in the one-year following childbirth in six regions of Ethiopia among adolescent girls and young women (AGYW). <b>Methods</b>: This paper uses panel data of women aged 15-24 who were interviewed during pregnancy and the postpartum period between 2019-2021 as part of the PMA Ethiopia survey (n=652).  <b>Results</b>: Despite the majority of pregnant and postpartum AGYW attending antenatal care (ANC), giving birth in a health facility, and attending vaccination visits, one-third or less of those who received the service reported discussion of FP at any of these visits. When considering the cumulative effect of discussions of FP at ANC, pre-discharge after childbirth, postnatal care and vaccination visits, we found that discussion of FP at a greater number of visits resulted in increased uptake of modern contraception by one-year postpartum. A greater number of FP discussions was associated with higher long-acting reversible contraceptive use relative to non-use and relative to short-acting method use. <b>Conclusions</b>: Despite high attendance, there are missed opportunities to discuss FP when AGYW access care.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"7 ","pages":"67"},"PeriodicalIF":0.0,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10168739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits, anxieties, acceptance, and barriers to the new injectable contraceptive DMPA-SC (Sayana Press): Clients’ perceptions in Sindh, Pakistan 效益,焦虑,接受和障碍,新的注射避孕药DMPA-SC (Sayana出版社):客户的看法在信德省,巴基斯坦
Pub Date : 2023-05-09 DOI: 10.12688/gatesopenres.14326.1
Ghulam Yaseen Veesar, T. Lashari, Roshan Fida, M. A. Veesar
Background: Injections are Pakistan's third most preferred contraceptive method because of their convenience. They represent a 2.5% share of the contraceptive prevalence rate (CPR) and contribute 10% to the current CPR. However, injections require a clinical setting or a healthcare provider for administration. A new method of subcutaneous presentation of depot medroxyprogesterone acetate (DMPA-SC), namely Sayana Press in Uniject™, has been introduced, which can be administered in nonclinical settings or self-administered by trained women. This study examined clients’ perceptions of the current depot medroxyprogesterone acetate-intramuscular injection (DMPA-IM) and its accessibility, availability, affordability, advantages, and disadvantages. In addition, it explored the benefits, barriers, and challenges regarding the new method of DMPA-SC (Sayana Press), especially considering self-injection. Methods: The study was conducted in Sindh, Pakistan. Three focus group discussions were conducted with 9–13 female participants with different demographic characteristics. A semi-structured questionnaire was used. The discussion was recorded, transcribed, and translated from Urdu or Sindhi to English. Transcripts were coded precisely, and data analysis was performed using NVivo software. Results: Participants expressed moderate fear of self-injection and risk of an inaccurate prick, suggesting that DMPA-SC acceptance may not be challenging at a community level. They appreciated free services at public health facilities, as the affordability of private facilities may be challenging for those with low income. Most participants agreed to pay PKR 50–300 (approximately 1 USD or less) as service charges for a private facility, while some agreed to pay for transportation costs when lacking alternative methods. Conclusions: DMPA-SC is a valuable alternative, provided its challenges are adequately addressed. Information about self-injection contraceptives is currently limited, and shared self-administration may be difficult without adequate training and counseling. Nevertheless, clients prefer the self-injection method for family planning to avoid transportation and private service charges.
背景:注射是巴基斯坦第三大首选避孕方法,因为它方便。她们占避孕普及率(CPR)的2.5%,对目前的CPR贡献了10%。然而,注射需要临床环境或医疗保健提供者进行管理。一种新的贮库醋酸甲羟孕酮(DMPA-SC)皮下给药方法,即Uniject中的Sayana Press™, 它可以在非临床环境中使用,也可以由受过训练的妇女自行管理。本研究调查了客户对目前储备的醋酸甲羟孕酮肌肉注射(DMPA-IM)的看法及其可及性、可用性、可负担性、优缺点。此外,它还探讨了DMPA-SC(Sayana Press)新方法的好处、障碍和挑战,特别是考虑到自注射。方法:本研究在巴基斯坦信德省进行。对9-13名具有不同人口特征的女性参与者进行了三次焦点小组讨论。采用半结构化问卷。讨论被记录、转录,并从乌尔都语或信德语翻译成英语。转录本被精确编码,数据分析使用NVivo软件进行。结果:参与者对自我注射和不准确穿刺的风险表示中度恐惧,这表明DMPA-SC在社区层面的接受可能并不具有挑战性。他们赞赏公共卫生设施的免费服务,因为私人设施的负担能力对低收入者来说可能很有挑战性。大多数参与者同意支付50-300巴基斯坦卢比(约1美元或以下)作为私人设施的服务费,而一些参与者则同意在缺乏替代方法时支付交通费用。结论:DMPA-SC是一种有价值的替代品,前提是其挑战得到充分解决。关于自我注射避孕药的信息目前有限,如果没有足够的培训和咨询,共享自我给药可能很困难。尽管如此,客户更喜欢自行注射计划生育方法,以避免交通和私人服务费用。
{"title":"Benefits, anxieties, acceptance, and barriers to the new injectable contraceptive DMPA-SC (Sayana Press): Clients’ perceptions in Sindh, Pakistan","authors":"Ghulam Yaseen Veesar, T. Lashari, Roshan Fida, M. A. Veesar","doi":"10.12688/gatesopenres.14326.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14326.1","url":null,"abstract":"Background: Injections are Pakistan's third most preferred contraceptive method because of their convenience. They represent a 2.5% share of the contraceptive prevalence rate (CPR) and contribute 10% to the current CPR. However, injections require a clinical setting or a healthcare provider for administration. A new method of subcutaneous presentation of depot medroxyprogesterone acetate (DMPA-SC), namely Sayana Press in Uniject™, has been introduced, which can be administered in nonclinical settings or self-administered by trained women. This study examined clients’ perceptions of the current depot medroxyprogesterone acetate-intramuscular injection (DMPA-IM) and its accessibility, availability, affordability, advantages, and disadvantages. In addition, it explored the benefits, barriers, and challenges regarding the new method of DMPA-SC (Sayana Press), especially considering self-injection. Methods: The study was conducted in Sindh, Pakistan. Three focus group discussions were conducted with 9–13 female participants with different demographic characteristics. A semi-structured questionnaire was used. The discussion was recorded, transcribed, and translated from Urdu or Sindhi to English. Transcripts were coded precisely, and data analysis was performed using NVivo software. Results: Participants expressed moderate fear of self-injection and risk of an inaccurate prick, suggesting that DMPA-SC acceptance may not be challenging at a community level. They appreciated free services at public health facilities, as the affordability of private facilities may be challenging for those with low income. Most participants agreed to pay PKR 50–300 (approximately 1 USD or less) as service charges for a private facility, while some agreed to pay for transportation costs when lacking alternative methods. Conclusions: DMPA-SC is a valuable alternative, provided its challenges are adequately addressed. Information about self-injection contraceptives is currently limited, and shared self-administration may be difficult without adequate training and counseling. Nevertheless, clients prefer the self-injection method for family planning to avoid transportation and private service charges.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43446083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia as reported in routinely collected data: the SPRINT retrospective cohort study. 根据常规收集的数据报告,马拉维、南非和赞比亚当天开始接受艾滋病毒治疗:SPRINT回顾性队列研究。
Pub Date : 2023-05-02 eCollection Date: 2023-01-01 DOI: 10.12688/gatesopenres.14424.2
Amy Huber, Kamban Hirasen, Alana T Brennan, Bevis Phiri, Timothy Tcherini, Lloyd Mulenga, Prudence Haimbe, Hilda Shakwelele, Rose Nyirenda, Bilaal Wilson Matola, Andrews Gunda, Sydney Rosen

Background: Since 2017 global guidelines have recommended "same-day initiation" (SDI) of antiretroviral treatment (ART) for patients considered ready for treatment on the day of HIV diagnosis. Many countries have incorporated a SDI option into national guidelines, but SDI uptake is not well documented. We estimated average time to ART initiation at 12 public healthcare facilities in Malawi, five in South Africa, and 12 in Zambia. Methods: We identified patients eligible to start ART between January 2018 and June 2019 from facility testing registers and reviewed their medical records from HIV diagnosis to the earlier date of treatment initiation or 6 months. We estimated the proportion of patients initiating ART on the same day or within 7, 14, 30, or 180 days of baseline. Results: We enrolled 825 patients in Malawi, 534 in South Africa, and 1,984 in Zambia. Overall, 88% of patients in Malawi, 57% in South Africa, and 91% in Zambia received SDI. In Malawi, most who did not receive SDI had not initiated ART ≤6 months. In South Africa, an additional 13% initiated ≤1 week, but 21% had no record of initiation ≤6 months. Among those who did initiate within 6 months in Zambia, most started ≤1 week. There were no major differences by sex. WHO Stage III/IV and tuberculosis symptoms were associated with delays in ART initiation;  clinic size and having a CD4 count done were associated with an increased likelihood of SDI. Conclusions: As of 2020, SDI of ART was widespread, if not nearly universal, in Malawi and Zambia but considerably less common in South Africa. Limitations of the study include pre-COVID-19 data that do not reflect pandemic adaptations and potentially missing data for Zambia. South Africa may be able to increase overall ART coverage by reducing numbers of patients who do not initiate ≤6 months.

背景:自2017年以来,全球指南建议对在艾滋病毒诊断当天被认为准备接受治疗的患者“当日开始”抗逆转录病毒治疗(ART)。许多国家已将SDI选项纳入国家指南,但SDI的使用情况没有很好的记录。我们估计了马拉维12个、南非5个和赞比亚12个公共医疗机构开始抗逆转录病毒治疗的平均时间。方法:我们从设施检测登记册中确定了2018年1月至2019年6月期间有资格开始抗逆转录病毒治疗的患者,并审查了他们从HIV诊断到更早开始治疗日期或6个月的医疗记录。我们估计了在基线的同一天或在7天、14天、30天或180天内开始抗逆转录病毒治疗的患者比例。结果:我们在马拉维招募了825名患者,在南非招募了534名患者,在赞比亚招募了1984名患者。总体而言,马拉维88%的患者、南非57%的患者和赞比亚91%的患者接受了SDI。在马拉维,大多数未接受SDI的患者≤6个月未开始抗逆转录病毒治疗。在南非,另外13%的人开始≤1周,但21%的人没有开始≤6个月的记录。在赞比亚6个月内开始治疗的患者中,大多数开始≤1周。性别差异不大。世卫组织III/IV期和结核病症状与延迟开始抗逆转录病毒治疗有关;临床规模和CD4计数与SDI的可能性增加有关。结论:截至2020年,抗逆转录病毒药物的SDI在马拉维和赞比亚很普遍,如果不是几乎普遍的话,但在南非却不那么普遍。该研究的局限性包括covid -19前的数据不能反映大流行的适应情况,以及赞比亚可能缺少的数据。南非可以通过减少≤6个月未开始接受抗逆转录病毒治疗的患者人数来增加总的抗逆转录病毒治疗覆盖率。
{"title":"Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia as reported in routinely collected data: the SPRINT retrospective cohort study.","authors":"Amy Huber, Kamban Hirasen, Alana T Brennan, Bevis Phiri, Timothy Tcherini, Lloyd Mulenga, Prudence Haimbe, Hilda Shakwelele, Rose Nyirenda, Bilaal Wilson Matola, Andrews Gunda, Sydney Rosen","doi":"10.12688/gatesopenres.14424.2","DOIUrl":"10.12688/gatesopenres.14424.2","url":null,"abstract":"<p><p><b>Background:</b> Since 2017 global guidelines have recommended \"same-day initiation\" (SDI) of antiretroviral treatment (ART) for patients considered ready for treatment on the day of HIV diagnosis. Many countries have incorporated a SDI option into national guidelines, but SDI uptake is not well documented. We estimated average time to ART initiation at 12 public healthcare facilities in Malawi, five in South Africa, and 12 in Zambia. <b>Methods:</b> We identified patients eligible to start ART between January 2018 and June 2019 from facility testing registers and reviewed their medical records from HIV diagnosis to the earlier date of treatment initiation or 6 months. We estimated the proportion of patients initiating ART on the same day or within 7, 14, 30, or 180 days of baseline. <b>Results:</b> We enrolled 825 patients in Malawi, 534 in South Africa, and 1,984 in Zambia. Overall, 88% of patients in Malawi, 57% in South Africa, and 91% in Zambia received SDI. In Malawi, most who did not receive SDI had not initiated ART ≤6 months. In South Africa, an additional 13% initiated ≤1 week, but 21% had no record of initiation ≤6 months. Among those who did initiate within 6 months in Zambia, most started ≤1 week. There were no major differences by sex. WHO Stage III/IV and tuberculosis symptoms were associated with delays in ART initiation;  clinic size and having a CD4 count done were associated with an increased likelihood of SDI. <b>Conclusions:</b> As of 2020, SDI of ART was widespread, if not nearly universal, in Malawi and Zambia but considerably less common in South Africa. Limitations of the study include pre-COVID-19 data that do not reflect pandemic adaptations and potentially missing data for Zambia. South Africa may be able to increase overall ART coverage by reducing numbers of patients who do not initiate ≤6 months.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"7 ","pages":"42"},"PeriodicalIF":0.0,"publicationDate":"2023-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160348.2/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9466571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol 社区卫生工作者领导的孟加拉国农村新生儿高胆红素血症家庭筛查和管理:一项集群随机对照试验方案
Pub Date : 2023-04-21 DOI: 10.12688/gatesopenres.14033.1
E. Foote, Farjana Jahan, Md. Mahbubur Rahman, S. Parvez, Tasnim Ahmed, Rezaul Hasan, F. Yeasmin, S. Arifeen, S. M. Billah, M. Hoque, Mohammad L. Shahidullah, Md. Shariful Islam, V. Bhutani, G. Darmstadt
Background: Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately high in low to middle income countries (LMIC) such as Bangladesh, and is largely preventable through timely treatment. Of the estimated 50% of newborns born in LMICs born at home, few receive screening or treatment for hyperbilirubinemia, leading to 6 million newborns per year who need phototherapy treatment for hyperbilirubinemia but are untreated. Household screening and treatment for neonatal hyperbilirubinemia with phototherapy administered by a trained community health worker (CHW) may increase indicated treatment for neonatal hyperbilirubinemia in comparison to the existing care system in Bangladesh. Methods: 530 Bangladeshi women in their 2nd or 3rd trimester of pregnancy from the rural community of Sakhipur, Bangladesh will be recruited for a cluster randomized trial and randomized to the intervention arm — home screening and treatment for neonatal hyperbilirubinemia — or the comparison arm to receive usual care. In the intervention arm, CHWs will provide mothers with two prenatal visits, visit newborns by 2 days of age and then daily for 3 days to measure transcutaneous bilirubin (TcB) and monitor clinical danger signs. Newborns without danger signs but with a TcB above the treatment threshold <15 mg/dL will be treated with light-emitting diode (LED) phototherapy at home. Newborns with danger signs or TcB >15 mg/dL will be referred to a hospital for treatment. Treatment rates for neonatal hyperbilirubinemia in each arm will be compared. Conclusion: This study will evaluate the effectiveness of CHW-led home phototherapy to increase neonatal hyperbilirubinemia treatment rates in rural Bangladesh. LMICs are expanding access to postnatal care by using CHWs, and our work will give CHWs a curative treatment option for neonatal hyperbilirubinemia. Similar projects in other LMICs can be pursued to dramatically extend healthcare access to vulnerable newborns with hyperbilirubinemia.
背景:在孟加拉国等中低收入国家,导致神经系统残疾和死亡的极端高胆红素血症比例过高,通过及时治疗在很大程度上可以预防。据估计,在家中出生的LMIC中,50%的新生儿中,很少有人接受高胆红素血症的筛查或治疗,导致每年有600万新生儿需要高胆红素血症的光疗治疗,但没有得到治疗。与孟加拉国现有的护理系统相比,由训练有素的社区卫生工作者(CHW)进行新生儿高胆红素血症的家庭筛查和光疗治疗可能会增加新生儿高胆红素血症的指示治疗。方法:来自孟加拉国萨基普尔农村社区的530名妊娠中期或晚期的孟加拉国妇女将被招募参加一项集群随机试验,并被随机分配到干预组(新生儿高胆红素血症的家庭筛查和治疗)或比较组接受常规护理。在干预组中,CHW将为母亲提供两次产前检查,在2天大之前对新生儿进行检查,然后在3天内每天进行检查,以测量经皮胆红素(TcB)并监测临床危险迹象。没有危险迹象但TcB高于治疗阈值15 mg/dL的新生儿将被转诊到医院接受治疗。将比较各组新生儿高胆红素血症的治疗率。结论:本研究将评估CHW主导的家庭光疗在提高孟加拉国农村新生儿高胆红素血症治疗率方面的有效性。LMIC正在通过使用CHW扩大产后护理的机会,我们的工作将为CHW提供新生儿高胆红素血症的治疗选择。可以在其他LMIC中开展类似的项目,以大幅扩大高胆红素血症弱势新生儿的医疗服务范围。
{"title":"Community health worker-led household screening and management of neonatal hyperbilirubinemia in rural Bangladesh: a cluster randomized control trial protocol","authors":"E. Foote, Farjana Jahan, Md. Mahbubur Rahman, S. Parvez, Tasnim Ahmed, Rezaul Hasan, F. Yeasmin, S. Arifeen, S. M. Billah, M. Hoque, Mohammad L. Shahidullah, Md. Shariful Islam, V. Bhutani, G. Darmstadt","doi":"10.12688/gatesopenres.14033.1","DOIUrl":"https://doi.org/10.12688/gatesopenres.14033.1","url":null,"abstract":"Background: Extreme hyperbilirubinemia leading to neurologic disability and death is disproportionately high in low to middle income countries (LMIC) such as Bangladesh, and is largely preventable through timely treatment. Of the estimated 50% of newborns born in LMICs born at home, few receive screening or treatment for hyperbilirubinemia, leading to 6 million newborns per year who need phototherapy treatment for hyperbilirubinemia but are untreated. Household screening and treatment for neonatal hyperbilirubinemia with phototherapy administered by a trained community health worker (CHW) may increase indicated treatment for neonatal hyperbilirubinemia in comparison to the existing care system in Bangladesh. Methods: 530 Bangladeshi women in their 2nd or 3rd trimester of pregnancy from the rural community of Sakhipur, Bangladesh will be recruited for a cluster randomized trial and randomized to the intervention arm — home screening and treatment for neonatal hyperbilirubinemia — or the comparison arm to receive usual care. In the intervention arm, CHWs will provide mothers with two prenatal visits, visit newborns by 2 days of age and then daily for 3 days to measure transcutaneous bilirubin (TcB) and monitor clinical danger signs. Newborns without danger signs but with a TcB above the treatment threshold <15 mg/dL will be treated with light-emitting diode (LED) phototherapy at home. Newborns with danger signs or TcB >15 mg/dL will be referred to a hospital for treatment. Treatment rates for neonatal hyperbilirubinemia in each arm will be compared. Conclusion: This study will evaluate the effectiveness of CHW-led home phototherapy to increase neonatal hyperbilirubinemia treatment rates in rural Bangladesh. LMICs are expanding access to postnatal care by using CHWs, and our work will give CHWs a curative treatment option for neonatal hyperbilirubinemia. Similar projects in other LMICs can be pursued to dramatically extend healthcare access to vulnerable newborns with hyperbilirubinemia.","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48352132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Gates Open Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1